|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.102
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.101
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.093
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.091
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.083
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.083
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.079
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.074
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.071
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.063
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.061
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.060
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.059
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.058
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.053
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.053
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.053
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.052
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.052
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.050
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.050
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.050
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.049
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.049
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.048
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.047
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.046
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.045
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.045
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.045
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.044
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.043
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.043
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.042
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.042
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.042
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.041
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.041
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.040
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.039
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.039
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.038
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.038
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.038
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.038
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.037
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.037
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.036
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.036
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.036
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.035
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.035
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.035
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.035
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.034
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.034
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.034
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.034
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.034
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.034
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.033
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.033
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.032
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.032
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.032
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.031
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.031
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.030
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.030
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.030
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.029
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.029
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.028
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.028
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.028
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.028
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.028
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.028
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.028
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.027
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.027
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.027
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.027
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.027
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.027
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.026
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.026
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.026
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.025
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.025
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.025
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.025
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.025
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.024
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.024
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.024
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.024
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.024
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.024
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.024
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.024
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.023
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.023
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.023
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.023
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.023
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.023
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.023
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.022
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.022
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.022
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.022
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.022
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.022
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.022
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.022
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.022
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.022
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.021
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.021
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.021
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.020
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.020
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.020
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.020
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.020
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.020
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.020
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.019
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.019
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.019
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.019
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.019
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.019
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.019
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.019
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.018
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.018
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.018
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.018
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.018
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.018
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.017
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.017
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.017
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.017
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.017
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.017
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.017
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.017
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.017
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.017
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.016
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.016
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.016
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.016
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.016
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.016
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.016
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.016
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.016
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.016
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.015
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.015
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.015
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.015
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.015
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.015
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.015
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.015
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.015
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.015
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.015
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.015
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.015
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.015
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.014
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.014
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.014
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.014
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.014
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.014
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.014
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.014
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.014
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.014
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.013
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.013
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.013
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.013
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.013
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.013
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.013
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
|
chemokine production
|
GO:0032602 |
34 |
0.013
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.013
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.013
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.013
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.012
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.012
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.012
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.012
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.012
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.012
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.012
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.012
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.012
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.012
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.012
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.012
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.012
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.012
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.012
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.012
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.012
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.012
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.012
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.012
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.012
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.012
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.012
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.012
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.011
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.011
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.011
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.011
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.011
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.011
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.011
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.011
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.011
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.011
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.011
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.011
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.011
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.011
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.011
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.011
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.011
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.011
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.011
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.011
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.011
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.011
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.011
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.011
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.011
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.011
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.011
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.011
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.011
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.011
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.011
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.011
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.011
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.011
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.011
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.011
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.011
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.011
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.011
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.011
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.011
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.011
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.011
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.011
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.011
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.011
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.011
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.011
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.011
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.010
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.010
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.010
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.010
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.010
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.010
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.010
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.010
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.010
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.010
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.010
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.010
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.010
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.010
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.010
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.010
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.010
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.010
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.010
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.010
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.010
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.010
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.010
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.010
|
|
